Rchr
J-GLOBAL ID:201801020192645440   Update date: Apr. 01, 2024

Ikumi Katano

Ikumi Katano
Research theme for competitive and other funds  (4):
  • 2022 - 2025 ヒトミクログリアが自然発生するヒト化マウスを用いた無菌環境での脳恒常性破綻の解明
  • 2016 - 2019 Development of in vivo cytotoxicity assay system using humanized mice maintaining human mature NK cells for long-term
  • 2013 - 2016 Development of in vivo cytotoxicity assay system using humanized mice increasing human natural killer cells
  • 2010 - 2015 Development of experimentation systems related to personalized medicine using humanized NOG mice
Papers (41):
more...
MISC (3):
  • A. Miyamoto, Katano, I, Y. Kikuchi, B. Tsuda, Y. Tokuda, M. Ito, S. Habu, Y. Kametani. The specific antibody production against HER2 peptide CH401MAP in NOG-IL4-Tg mice. EUROPEAN JOURNAL OF IMMUNOLOGY. 2016. 46. 1218-1218
  • Caroline Mignard, Jean-Francois Mirjolet, Olivier Duchamp, Yasuyuki Ohnishi, Ikumi Katano, Mamoru Ito. Pharmacodynamic evaluation of ADCC mediated effects in humanized IL2 or IL15 NOG mice models. CANCER RESEARCH. 2014. 74. 19
  • Caroline Mignard, Olivier Duchamp, Jean-Francois Mirjolet, Yasuyuki Ohnishi, Ikumi Katano, Mamoru Ito. In vivo ADCC-mediated antitumor activity study with new preclinical humanized models. MOLECULAR CANCER THERAPEUTICS. 2013. 12. 11
Professional career (1):
  • 博士(医学) (慶應義塾大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page